From: Moxibustion in the management of irritable bowel syndrome: systematic review and meta-analysis
Study (year) Country | Sample size (% female) | Diagnostic criteria used for IBS | Type of IBS (based on the predominant stool form) | Criteria used to define symptom improvement | Moxa intervention (duration)* | Control intervention (duration) | Risk of bias assessmenta |
---|---|---|---|---|---|---|---|
Moxa/AT vs. sham moxa/AT | |||||||
Anastasi (2009) USA [18] | 29 (66%) | Rome III and negative GI investigations | Unspecified | Changes in CGIS | Moxa and AT (4 weeks): Indirect and individualised, twice weekly | Sham moxa and sham AT (4 weeks): Superficial needling at non-acupoints/moxa above and away from acupoints | U-U-Y-Y-U-Y |
Moxa/AT vs. pharmacological medications | |||||||
Chen (2011) China [19] | 59 (53%) | Rome III, negative GI investigations and TCM criteria | D 100% | ≥ 30% improvement in global IBS symptoms | Moxa and AT (3 weeks): Indirect and partially individualised, o.d., 5 sessions/course, 3 courses in total | Medication (3 weeks): | Y-Y-N-N-Y-Y |
- Smecta 1 bag/time b.d. | |||||||
- Loperamide 4 mg/time t.i.d. and pinaverium bromide 50 mg/time t.i.d. if diarrhea did not stop | |||||||
Zeng (2010) China [35] | 65 (58%) | Rome III | D 100% | ≥ 50% improvement in global IBS symptoms | Moxa and AT (1 month): Indirect and partially individualized, o.d., 10 sessions/course in dog days | Medication (1 month): Trimebutine maleate 100 mg/time, t.i.d. | Y-Y-N-N-Y-Y |
Xue (2009) China [34] | 200 (51%) | Rome II and TCM criteria | Unspecified | Any improvement in global IBS symptoms | Moxa and AT (23–49 days): Fixed, o.d. for 10 sessions (1 course), 2–4 courses in total, with 3 days of no TX interval | Medication (23–49 days): Sulfasalazine 10 mg/kg, o.d. for 10 days (1 course), 2–4 courses in total | U-U-N-N-Y-Y |
Wang (2008) China [31] | 110 (unspecified) | Rome II | D 100% | ≥ 30% improvement in global IBS symptoms | Warming needle (23 days): Fixed, o.d. for 10 sessions (1 course), 2 courses in total, with 3 days of no TX interval | Medication (23 days): Smecta, 1 bag/time t.i.d. | U-U-N-N-Y-Y |
Moxa plus other treatments vs. other treatments | |||||||
Hu (2012) China [21] | 64 (22%) | Rome III, negative GI investigations and TCM criteria | D 100% | ≥ 30% improvement in global IBS symptoms | Moxa and AT (8 weeks): | AT (8 weeks): Partially individualized, o.d., 5 sessions/week, 20 sessions/course, 2 courses in total | Y-U-N-N-Y-Y |
- Moxa: indirect and partially individualized, o.d., 5 | |||||||
sessions/week, 20 sessions/course, 2 courses in total | |||||||
- AT: partially individualized, o.d., 5 sessions/week, 20 sessions/course, 2 courses in total | |||||||
Shang (2012) China [29] | 48 (58%) | Rome II and negative GI investigations | D 100% | Any improvement in global IBS symptoms | Moxa/AT and medication (30 days): Indirect and fixed, o.d., 10 sessions/course, 3 courses in total | Medication and dietary advice (30 days): | U-U-N-N-Y-Y |
- GI antispasmodic drugs, antidiarrheal drugs, anti-anxiety drugs, and intestinal flora regulating drugs | |||||||
Jiang (2010) China [23] | 60 (57%) | Rome II and negative GI investigations | D 100% | Any improvement in global IBS symptoms | Moxa and medication (4 weeks): | Medication (4 weeks): Trimebutine 0.2 g/time, t.i.d. | U-U-N-N-U-N |
- Moxa: ginger-partitioned and fixed, o.d. for 7 sessions (1 course), 4 courses in total, with 1 day of no TX interval | |||||||
- Medication: Trimebutine 0.2 g/time, t.i.d. | |||||||
Wang (2009) China [30] | 60 (55%) | Rome II and TCM criteria (liver-qi stagnation with spleen deficiency type) | D 100% | Any improvement in global IBS symptoms | Moxa and herbal medicine (1 month): | Herbal medicine (1 month): Partially individualised | U-U-N-N-Y-Y |
- Moxa: indirect and fixed, o.d. | |||||||
- Herbal medicine: partially individualised | |||||||
Xiong (2008) China [33] | 120 (60%) | Rome II, negative GI investigations and TCM criteria (liver-qi stagnation with spleen deficiency type) | D 100% | ≥ 30% improvement in global IBS symptoms | AT/warming needle and herbal medicine (4 weeks): | Herbal medicine (4 weeks): Fixed, b.d. | U-U-N-N-Y-Y |
- AT/warming needle: fixed, no information on sessions | |||||||
- Herbal medicine: fixed, b.d. | |||||||
Huang (2007) China [22] | 61 (unspecified) | Rome III, negative GI investigations and TCM criteria | Unspecified | Any improvement in global IBS symptoms | Moxa and colon hydrotherapy (4 weeks): | Colon hydrotherapy (4 weeks): Twice weekly for constipation, once weekly for diarrhea | U-U-N-N-Y-Y |
- Indirect and partially individualized, o.d. | |||||||
- Colon hydrotherapy: twice weekly for constipation, once weekly for diarrhea | |||||||
Liu (1997) [24] China | 150 (41%) | Only stated that “all participants had IBS and no organic GI disease” | Unspecified | Any improvement in global IBS symptoms | AT/moxa and psychotherapy (10–75 days): Individualised AT followed by indirect and fixed moxa, once every other day for 10 sessions (1 course), 1–6 courses, with 3–5 days of no TX interval | Psychotherapy (7–42 days): 1–2 sessions/week (1 course), 1–6 courses, each session performed ahead of AT | Y-U-N-N-N-Y |
Moxa/AT vs. probiotics | |||||||
An (2010) China [17] | 81 (62%) | Rome II | Unspecified | ≥ 30% improvement in global IBS symptoms | Moxa and AT (4 weeks): Indirect and fixed, o.d. for 12 sessions (1 course), 2 courses in total, with 3 days of no TX interval | Bifid triple viable capsules (4 weeks): Bifidobacterium longum, Lactobacillus acidophillus, and Enterococcus faecalis 420 mg (2 capsules)/time, t.i.d. | Y-U-N-N-Y-Y |